OBJECTIVES:Polypharmacy (PP) and potentially inappropriate medications (PIM) are common in older adults with cancer, increasing the risk of adverse outcomes. Approaches to identifying and addressing PP/PIM are needed. MATERIALS AND METHODS: Patients≥70 years with advanced cancer were enrolled in this cluster-randomized study. All underwent geriatric assessment (GA), and oncologists randomized to the intervention arm received GA-driven recommendations; no information was provided to oncologists at usual care sites. For patients with PP (≥5 medications or ≥1 high-risk medication), clinic visits with treating oncologists were audiorecorded and transcribed, and discussions regarding PP/PIM identified. Quality of provider response was coded as dismissed, mentioned, acknowledged, or addressed. RESULTS: Forty patient transcripts were analyzed (20 per arm). More discussions occurred in the intervention group (n = 81) versus the usual care group (n = 51). More concerns per patient were brought up in the intervention group (4.1 vs. 2.6, p = 0.07). Physician-initiated discussions were higher in the intervention group (73% vs. 49%, p = 0.006). More PP concerns were "addressed" in the intervention group (59% vs. 45%, p = 0.1). Oncology supportive care medication concerns were more often addressed in the usual care group (58% vs. 18%, p = 0.008), but medication management concerns were addressed more commonly in the intervention group (38% vs. 79%, p = 0.003). CONCLUSION: In this secondary analysis, a GA-driven intervention increased PP discussions, particularly about total number of medications and medication management. PP/PIM concerns were more commonly addressed in the intervention group, except for the subset of conversations about supportive care medications.
RCT Entities:
OBJECTIVES: Polypharmacy (PP) and potentially inappropriate medications (PIM) are common in older adults with cancer, increasing the risk of adverse outcomes. Approaches to identifying and addressing PP/PIM are needed. MATERIALS AND METHODS:Patients ≥70 years with advanced cancer were enrolled in this cluster-randomized study. All underwent geriatric assessment (GA), and oncologists randomized to the intervention arm received GA-driven recommendations; no information was provided to oncologists at usual care sites. For patients with PP (≥5 medications or ≥1 high-risk medication), clinic visits with treating oncologists were audiorecorded and transcribed, and discussions regarding PP/PIM identified. Quality of provider response was coded as dismissed, mentioned, acknowledged, or addressed. RESULTS: Forty patient transcripts were analyzed (20 per arm). More discussions occurred in the intervention group (n = 81) versus the usual care group (n = 51). More concerns per patient were brought up in the intervention group (4.1 vs. 2.6, p = 0.07). Physician-initiated discussions were higher in the intervention group (73% vs. 49%, p = 0.006). More PP concerns were "addressed" in the intervention group (59% vs. 45%, p = 0.1). Oncology supportive care medication concerns were more often addressed in the usual care group (58% vs. 18%, p = 0.008), but medication management concerns were addressed more commonly in the intervention group (38% vs. 79%, p = 0.003). CONCLUSION: In this secondary analysis, a GA-driven intervention increased PP discussions, particularly about total number of medications and medication management. PP/PIM concerns were more commonly addressed in the intervention group, except for the subset of conversations about supportive care medications.
Authors: Arti Hurria; Ilene S Browner; Harvey Jay Cohen; Crystal S Denlinger; Mollie deShazo; Martine Extermann; Apar Kishor P Ganti; Jimmie C Holland; Holly M Holmes; Mohana B Karlekar; Nancy L Keating; June McKoy; Bruno C Medeiros; Ewa Mrozek; Tracey O'Connor; Stephen H Petersdorf; Hope S Rugo; Rebecca A Silliman; William P Tew; Louise C Walter; Alva B Weir; Tanya Wildes Journal: J Natl Compr Canc Netw Date: 2012-02 Impact factor: 11.908
Authors: Arti Hurria; Kayo Togawa; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Smita Bhatia; Vani Katheria; Shira Klapper; Kurt Hansen; Rupal Ramani; Mark Lachs; F Lennie Wong; William P Tew Journal: J Clin Oncol Date: 2011-08-01 Impact factor: 44.544
Authors: Julian Lindsay; Michael Dooley; Jennifer Martin; Michael Fay; Alison Kearney; Mohsina Khatun; Michael Barras Journal: Support Care Cancer Date: 2014-07-01 Impact factor: 3.603
Authors: Lee A Kehoe; Huiwen Xu; Paul Duberstein; Kah Poh Loh; Eva Culakova; Beverly Canin; Arti Hurria; William Dale; Megan Wells; Nikesha Gilmore; Amber S Kleckner; Jennifer Lund; Charles Kamen; Marie Flannery; Mike Hoerger; Judith O Hopkins; Jane Jijun Liu; Jodi Geer; Ron Epstein; Supriya G Mohile Journal: J Am Geriatr Soc Date: 2019-03-29 Impact factor: 5.562
Authors: Nikesha Gilmore; Huiwen Xu; Lee Kehoe; Amber S Kleckner; Kiran Moorthi; Lianlian Lei; Mostafa R S Mohamed; Kah Poh Loh; Eva Culakova; Marie Flannery; Erika Ramsdale; Paul R Duberstein; Beverly Canin; Charles Kamen; Gilbert Giri; Erin Watson; Amita Patil; Adedayo A Onitilo; Brian Burnette; Michelle Janelsins; Supriya G Mohile Journal: Cancer Date: 2021-11-11 Impact factor: 6.921
Authors: S Yilmaz; M C Janelsins; M Flannery; E Culakova; M Wells; P-J Lin; K P Loh; R Epstein; C Kamen; A S Kleckner; S A Norton; S Plumb; S Alberti; K Doyle; M Porto; M Weber; N Dukelow; A Magnuson; L A Kehoe; G Nightingale; M Jensen-Battaglia; K M Mustian; S G Mohile Journal: J Geriatr Oncol Date: 2022-03-12 Impact factor: 3.929
Authors: Marielle Jensen-Battaglia; Lianlian Lei; Huiwen Xu; Lee Kehoe; Amita Patil; Kah Poh Loh; Erika Ramsdale; Allison Magnuson; Amber S Kleckner; Tanya M Wildes; Po-Ju Lin; Karen M Mustian; Gilbert Giri; Mary Whitehead; James Bearden; Brian L Burnette; Jodi Geer; Supriya G Mohile; Richard F Dunne Journal: JAMA Netw Open Date: 2022-03-01
Authors: Amber S Kleckner; Megan Wells; Lee A Kehoe; Nikesha J Gilmore; Huiwen Xu; Allison Magnuson; Richard F Dunne; Marielle Jensen-Battaglia; Mostafa R Mohamed; Mark A O'Rourke; Nicholas J Vogelzang; Elie G Dib; Luke J Peppone; Supriya G Mohile Journal: JCO Oncol Pract Date: 2021-07-06